Trifork is a leading full service supplier of high-quality custom-built applications and end-to-end solutions.  Providing a lean approach to support each phase of the project life-cycle from idea creation, development and to ongoing maintenance and support.  They aim to empower their customers by providing expert advice on the optimization of business critical IT systems and cutting-edge technology. Enabling their customers to seamlessly integrate and use these technologies – bringing immediate value to their customers’ business and customers.  Trifork delivers solutions for the educational, finance, public, healthcare, manufacturing and telecom industries.

Trifork

FTSE 100 Listed Healthcare Company

Founded as an investment firm focusing on the most promising startups, we have evolved into a unique set of private market funds investing globally in equity and debt across complementary sectors and stages. We fuse traditional values with a contemporary approach and balance exacting processes with the agility to capture commercial opportunity and compelling investment returns. Our continuous search for new opportunities has led us to create a balanced collection of complementary funds and relationships.

Salica

Ascension is an early-stage VC built by exited entrepreneurs to back the next generation of tech and impact founders. Run by an experienced and diverse team of successful entrepreneurs, we have been relentlessly dedicated to finding the UK’s best Seed-stage startups since 2014. Ascension benefits from the active industry connections essential for the sourcing and development of deal-flow and due diligence. The team has co-invested with the UK’s leading angels and VCs, key to securing follow-on funding as the portfolio businesses move to their next stage of growth. We believe in building an inclusive, community driven brand that can benefit the wider UK tech ecosystem and strive to work with conviction, integrity, humour, and humility.

Ascension

R42 Group actively invents and finances deep science ventures. R42 Group will work from the pre-seed inventing stage through to the growth stage.

R42 Group

ExSeed Health

ExSeed Health Test and improve the quality of your sperm from the comfort of your home with thier smartphone device and intelligent lifestyle app.

Headquartered in the UK, ExSeed provides a sperm test kit to measure the total motile sperm count, which is the amount of sperm that could possibly reach the egg. It does so by measuring the volume, concentration, and motility of the sperm, which the company claims has a proven accuracy of over 95%. As of February 2021, ExSeed was licensed for sale in the UK and Europe. In addition to the sperm test kit, the company also offers a sperm lifestyle program and sperm supplements to help users increase the health and motility of their sperm.&nbsp;&nbsp;

Long-term demographic changes are finally bringing fertility technologies into focus.

Fertility Tech

ExSeed

ExSeed Health on LinkedIn: #malefertility #exseed #medicaldevices #medtech

Headquartered in the UK, ExSeed provides a sperm test kit to measure the total motile sperm count, which is the amount of sperm that could possibly reach the egg. It does so by measuring the volume, concentration, and motility of the sperm, which the company claims has a proven accuracy of over 95%. As of February 2021, ExSeed was licensed for sale in the UK and Europe. In addition to the sperm test kit, the company also offers a sperm lifestyle program and sperm supplements to help users increase the health and motility of their sperm.&nbsp;&nbsp;&nbsp;ExSeed’s kit enables the sperm to be analyzed at home, and the device can be connected to a smartphone to provide the details of the sperm analysis to the customer. This is different from peers like Dadi and Legacy, which require the sample to be mailed in.&nbsp;&nbsp;Key customers and partnerships&nbsp;ExSeed collaborated with fertility clinics, sperm banks, distributors, pharmacies, and online affiliates to integrate its home sperm test kits into their offerings. These partnerships enable healthcare providers to offer patients a convenient, at-home testing option, with results accessible through a dedicated dashboard for monitoring and consultation.&nbsp;In February 2021, ExSeed partnered with women’s ovulation tracking device manufacturer, Fertility Focus, to offer its products as a holistic fertility tracking and testing solution for men and women.&nbsp;&nbsp;

Glow offers apps that track data related to women’s fertility including ovulation cycle and pregnancy tracking. In addition to apps, the company also offers individualized fertility coaching, clinic identification and community support, and links patients with clinics for procedures such as egg freezing.&nbsp;In 2020, the company faced investigations into privacy and security failures involving its app. Glow agreed to pay a USD 0.25 million settlement in September 2020.&nbsp;Key customers and partnershipsAs of&nbsp;November 2024, it had 25 million+ users and claims to have helped about 1.7 million women get pregnant. Glow's user base includes women from various industries seeking to monitor their reproductive health. The company has established partnerships with healthcare providers to enhance its offerings.In March 2024, Glow partnered with Natalist to offer its users exclusive access to Natalist’s products and resources including prenatal vitamins and supplements, educational resources on a variety of reproductive health topics, and support from a team of registered nurses and lactation consultants.In February 2024, the company partnered with Mira to provide its users with education on hormone health, hormone tracking, and exclusive discounts on Mira Hormone Monitor: Max Kit and Fertility Max Wands.&nbsp;

Glow

Inne, based in Germany, offers an at-home mini lab kit for women. Hormone analysis is conducted based on saliva samples. The lab device connects to smartphones for storage and access to the analysis results.Unlike peer offerings, Inne does not attempt to predict future cycles and fertility dates, and instead educates users about their bodies, with information on what changes they should feel in response to the hormonal levels on the day.&nbsp;Key customers and partnershipsIn<a href="https://www.femtechworld.co.uk/news/start-up-inne-raises-us10m-to-expand-hormone-tracking-platform/?utm_source=chatgpt.com"> May 2022</a>, Inne announced a strategic partnership with Phenology. The collaboration aimed to introduce Inne's hormone-tracking technology to the US market, focusing on assisting women in tracking hormonal changes during perimenopause.&nbsp;

Inne

Proov (formerly known as MFB Fertility) offers the at-home “Proov'' ovulation and progesterone test. Proov tracks hormone levels in urine over multiple days, after suspected ovulation, and estimates whether the progesterone levels are sufficient for implantation, during the 7-10 day implantation window.Proov was the first FDA-cleared urine PdG (urine metabolite of the progesterone hormone) test and its method of determining the fertile window was patented&nbsp;in 2021. Moreover, it received the CE marking and expanded its sales footprint to Europe in June 2021.&nbsp;Key customers and partnershipsIn June 2024, Proov partnered with Wisp to integrate Proov's at-home fertility tests into Wisp's services. This collaboration aimed to offer comprehensive fertility care, including ovulation medications and testing, to individuals seeking to conceive.In July 2023, Proov collaborated with Quest Diagnostics to make the Proov Confirm PdG home collection kit available through questhealth.com. This test is claimed to be the first FDA-cleared PdG (progesterone metabolite) home test kit designed to confirm successful ovulation. The partnership aimed to broaden access to Proov's testing solutions.&nbsp;&nbsp;

Proov

Progyny works with employers (primarily large enterprises in the US) to optimize the fertility benefits they offer for their employees. It connects employees to fertility specialists and clinics, and also offers extensive support to patients through their Progyny Patient Care Advocates, who provide clinical guidance, education, and emotional support.The company was founded as a fertility education platform and eventually included in vitro fertilization (IVF) referral network Fertility Authority and reproductive health company Auxogyn, into its network. The company pivoted into offering fertility benefit solutions in 2016, and launched Progyny Rx (fertility medication benefit) in 2018.Progyny connects patients to a network of 800 fertility specialists and nearly 600 clinic locations.&nbsp;Progyny’s revenue exceeded USD 1 billion for the first time in FY 2023 and cash flow from operations were recorded as USD 188.8 million for the period. Adjusted EBITDA for the period was USD 187.1 million, a 49% increase YoY from the USD 125.7 million reported in FY 2022.Key customers and partnershipsAs of March 2022, the company served 264 enterprise customers (including Facebook, Microsoft, Google, and Nasdaq), and had 3.9 million active members.In March 2023, Progyny was selected as the exclusive partner for fertility and family building benefits by CHA, representing over 220 children's hospitals with more than 2 million covered lives. This partnership enabled CHA member hospitals to offer comprehensive fertility solutions to their employees.

Progyny

Prima Temp offers the artificial intelligence (AI) assisted “Priya” intravaginal ring sensor and accompanying app to continuously measure a woman’s core body temperature, predicting fertility windows. The app uses big data to improve its predictions, and the app notifies the user of fertile windows. The company also offers the “Kindara” fertility tracking app, which provides fertility-related education and links users to a community of over 140,000 members.&nbsp;&nbsp;&nbsp;Key customers and partnerships&nbsp;In&nbsp;<a href="https://www.prnewswire.com/news-releases/enfamil-and-prima-temp-enter-collaboration-to-support-women-on-fertility-journey-301111251.html?utm_source=chatgpt.com">August 2020</a>, Prima-Temp entered a co-marketing agreement with infant formula brand Enfamil to offer educational resources and discounts on products and services, including Enfamom prenatal vitamins and Prima-Temp's fertility tracking solutions.&nbsp;In&nbsp;<a href="https://www.prnewswire.com/news-releases/prima-temp-announces-new-team-and-new-international-initiative-300604615.html?utm_source=chatgpt.com">February 2018</a>, the company entered into an exclusive licensing and distribution agreement with Hungarian pharmaceutical company Gedeon Richter to commercialize its Priya fertility sensor globally (excluding the US and Canada). The collaboration aimed to leverage Gedeon Richter's global network to bring the Priya sensor to international markets.

Prima Temp

Test kits which use saliva, blood, or temperature to determine hormone levels and form conclusions on fertility and fertility cycles.


Apps which use data science to identify fertility windows.

Organizations that freeze eggs or embryos for usage at a future date.


Services that analyze sperm samples (via test kit) and/or offer storage facilities for future use.

Companies specializing in supporting patient decision making, financing, clinical visits, physician referrals, and at-home treatments

Offers digital platforms and apps to provide fertility-related support

Uses AI/ML to improve cycle predictions and track symptoms

Some startups use genetic screening to tailor treatment or identify underlying issues

ExSeed

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless